FDA panel backs plan for annual COVID-19 booster, as new omicron subvariant continues to dominate in new cases
Published
A Food and Drug Administration advisory panel voted unanimously Thursday for Americans to get a once-a-year booster against COVID-19, with the strain to be decided midyear for a fall campaign, the Associated Press reported. “This is a consequential meeting to determine if we’ve reached the point…
#fda #davidkaslow #pfizerpfe #modernamrna #cdc #newjersey #usvirginislands #puertorico #denmark #ireland